New Zealand

Resilience System


You are here

Symptoms

New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers

A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.

..

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Vaccination cuts by 27% the risk of long COVID --study

COVID-19 vaccination slashed the risk of experiencing prolonged symptoms by about 27% in fully vaccinated adults who were later infected, estimates a European Centre for Disease Prevention and Control (ECDC) systematic review of 12 studies.

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Symptoms
howdy folks
Page loaded in 0.641 seconds.